Dr. Ramya Dwivedi

Dr. Ramya Dwivedi

Feature Writer

Ph.D. Biotechnology

Ramya has a Ph.D. in Biotechnology from the National Chemical Laboratories (CSIR-NCL), in Pune. Her work consisted of functionalizing nanoparticles with different molecules of biological interest, studying the reaction system and establishing useful applications.

See more

She also has had exposure to research in molecular biology, immunology, evolutionary biology, chemistry, AFM imaging and analysis, and spectroscopy. Her interests cover interdisciplinary sciences.

She enjoyed teaching ‘Physics in Nanoscience and Nanotechnology’ as an Assistant Professor at SRM University. After a short period there, she pursued research further as the prestigious CSIR Nehru Science Post Doctoral Fellow in the field of Nanosciences.

Her research helped her skill for writing manuscripts, news articles, and reviews. She has also contributed as a peer reviewer for journals from RSC and ACS publications. After a maternity break and raising two daughters, Ramya is now working to get back into learning, research, and writing.

When Ramya is not immersed in a book, she loves to cook, travel and play with her daughters. She lives in Chennai. She is also a budding gardener. She strongly believes in doing her bit for the environment and in healthy living.

She has recently finished an online course: ‘Writing in the Sciences’, offered by Stanford University. Presently Ramya sees her freelance writing as a primer to her endeavors in science.

See less

Articles from Ramya

Could antiviral surface designs help reduce SARS-CoV-2’s spread?

Could antiviral surface designs help reduce SARS-CoV-2’s spread?

Nanoparticle (SpFN) vaccine candidate elicits multifactorial cellular immune responses against SARS-CoV-2 in vivo

Nanoparticle (SpFN) vaccine candidate elicits multifactorial cellular immune responses against SARS-CoV-2 in vivo

Mechano-immunological response to SARS-CoV-2

Mechano-immunological response to SARS-CoV-2

Study of 180 breastfeeding mothers after mRNA COVID-19 vaccination

Study of 180 breastfeeding mothers after mRNA COVID-19 vaccination

What is the role of nanotechnology in the current COVID-19 outbreak?

What is the role of nanotechnology in the current COVID-19 outbreak?

Researchers develop eleven SARS-CoV-2 RBD nanobodies using computational design

Researchers develop eleven SARS-CoV-2 RBD nanobodies using computational design

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

Researchers aim to better understand clinical features associated with COVID-19 mortality

Researchers aim to better understand clinical features associated with COVID-19 mortality

SARS-CoV-2 pandemic underscores importance of understanding evolution of RNA genomes

SARS-CoV-2 pandemic underscores importance of understanding evolution of RNA genomes

Could virosome-based nanovaccines be a promising new approach to preventing viral diseases?

Could virosome-based nanovaccines be a promising new approach to preventing viral diseases?

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.